DEBRA WALZ: Open Payments
NPI 1194045765 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 9 payments from 8 companies in 2025. Trend: 2023 $2,733 · 2024 $2,969 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| Novocure Inc. | 1 | $43 |
| GENZYME CORPORATION | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: LIBTAYO, REBLOZYL, Optune Lua (NovoTTF-200T), JEMPERLI, OJJAARA, SARCLISA, KEYTRUDA, ALUNBRIG.
Industry payments across NY — which companies pay providers there.
